The influence of SARS‐CoV‐2 infection on expression of drug‐metabolizing enzymes and transporters in a hACE2 murine model

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and the resulting Coronavirus disease 2019 emerged in late 2019 and is responsible for significant morbidity and mortality worldwide. A hallmark of severe COVID‐19 is exaggerated systemic inflammation, regarded as a “cytokine sto...

Descripción completa

Detalles Bibliográficos
Autores principales: Deshpande, Kiran, Lange, Keith R., Stone, William B., Yohn, Christine, Schlesinger, Naomi, Kagan, Leonid, Auguste, Albert J., Firestein, Bonnie L., Brunetti, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155506/
https://www.ncbi.nlm.nih.gov/pubmed/37133236
http://dx.doi.org/10.1002/prp2.1071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155506/
https://www.ncbi.nlm.nih.gov/pubmed/37133236
http://dx.doi.org/10.1002/prp2.1071

Ejemplares similares